Deep sclerectomy in XXXX with @entity9998 .

@entity1 @entity725 @entity9998 @entity726 @entity5891
PURPOSE: To compare the results of deep sclerectomy in @entity9998 ( @entity9998 ) with those in @entity725 ( @entity725 ). METHODS: This consecutive, prospective study comprised 24 @entity9998 @entity1 (28 eyes) and 25 @entity725 @entity1 (29 eyes) who underwent deep sclerectomy. Two different implants were used: either an absorbable collagen implant (Aqua-Flow) or a non-absorbable hydrophilic acrylic implant (T-Flux). The number of @entity726 medications, intraocular pressure (IOP) and complications were compared postoperatively. The definition of complete success was IOP below 19 mmHg without therapy. RESULTS: After a mean follow-up of 19.9 +/- 10.9 months (range 6-36 months) in the @entity9998 group and 16.2 +/- 10.0 months (range 6-36 months) in the @entity725 group, complete success was seen in 60.7% and in 37.9% of eyes, respectively (p=0.085). After adjustments for disparities in baseline characteristics, survival analysis demonstrated that success rates were better over time in @entity9998 eyes than in @entity725 eyes (p=0.038). At all time-points, except at 24 months, the IOP was lower in the @entity9998 group than in the @entity725 group. This difference was statistically significant at 1 week (p=0.050) and 3 months (p=0.006). At 18 months, the mean decrease in number of medications was 77.3% in the @entity9998 group and 65.9% in the @entity725 group (not statistically significant). Levelled @entity5891 occurred more frequently in @entity9998 eyes (35.7%) than in @entity725 eyes (13.8%). CONCLUSION: Capsular @entity726 @entity1 had significantly higher success rates over time than @entity725 @entity1 following deep sclerectomy with implant.
